The NIH Clinical Center
GMB Cellular Therapy Clinical Research: For Patients
Patient Care
In the United States, there are more than 11,000 deaths from HPV-associated cancers annually. Our team is committed to improving outcomes for patients with these diseases through cutting-edge basic and clinical research. Patients with HPV+ cancers or premalignant conditions, recurrent respiratory papillomatosis (RRP), and other diseases may be enrolled on a clinical trial and receive therapy at the NIH Clinical Center.
Our team specialized in the study and treatment of HPV-associated malignancies and disorders. We are currently evaluating patients with:
- Oropharyngeal (throat)
- Anal Cancer
- Cervical Cancer
- Penile Cancer
- Vaginal Cancer
- Vulvar Cancer
- Recurrent Respiratory Papillomatosis
All our patients receive individualized, high-quality care at the NIH Clinical Center, America’s research hospital. Located in Bethesda, Maryland, the NIH Clinical Center